Ask the Expert: Dementia in Parkinson's (2020)

Dr. Naaz Parmar, a geriatric medicine specialist and founder of the Pacific Geriatricians Group, presented a talk focusing on dementia's comprehensive aspects, covering its definition, assessment, subtypes, treatment options, and the significance of early detection. Stressing early intervention's impact on management and prognosis, she urged seeking medical help upon experiencing memory changes.

The webinar detailed the cognitive review process, diagnostic steps involving memory tests, blood work, and scans, and delineated subtypes like Alzheimer's and vascular dementia along with their symptoms and causes. Prevention through physical activity and health condition management was emphasized, alongside insights into Parkinson's dementia and Lewy body dementia.

Regarding treatment, Dr. Parmar highlighted the absence of a cure for dementia, emphasizing the need for regular follow-ups and assembling a care team. Lifestyle changes, mental and physical stimulation, and medications like cholinesterase inhibitors for mild to moderate dementia were discussed, considering individual preferences and potential side effects.

Furthermore, the talk delved into first-line medications—donepezil, galantamine, and rivastigmine—for dementia, their efficacy concerning severity and side effects. It also covered medication options like citalopram, mirtazapine, and sertraline for behavioral and anxiety-related changes in dementia patients. Dr. Parmar stressed the significance of familial support, support groups, case managers, education, counselling, safety measures, and lifestyle adjustments for dementia patients and their families.

View the video slides accompanying this presentation by clicking here.

**Disclaimer: These sessions are designed to provide general education and are not intended for individual advice and/or clinical care. The information conveyed in this recording was accurate at the time of presentation.**